Insights On Outsourced Drug Development
-
Characterize Lentiviral Vector Quality Attributes Using CE Platform Technology
8/14/2023
Review this outline of a platform-based approach using capillary electrophoresis (CE) to mitigate the technical difficulties in characterizing LVVs for the assessment of multiple quality attributes.
-
Creating A Shigella Infection Model Using Organs-On-Chips
4/9/2024
Learn how researchers have utilized Organs-on-Chips technology to test the infectivity of Shigella through several experimental approaches.
-
Proximal Tubule Kidney-Chip For Modeling Human Physiology
3/14/2024
Discover how an Organ-Chip can be used to create a comprehensive recapitulation of the proximal tubule, addressing the need for more human-relevant preclinical models in the pharmaceutical industry.
-
Microphysiological Systems: The Future Of Research And Drug Development
2/14/2024
Discover how microphysiological systems are revolutionizing the life sciences, offering a more accurate and reliable approach to studying human physiology and developing promising new drugs.
-
How To Prepare Your Specimen For Immunofluorescence Microscopy
5/30/2023
What is Immunofluorescence (IF) Microscopy, and how do you perform IF procedures to acquire the best quality data?
-
A New Mindset For Combination Product Development
6/15/2022
As we balance the time-to-market and risk for novel therapies, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift.
-
The Future Of Preclinical Animal Models In Drug Discovery
5/10/2024
The paradigm shift from animal to human Organ-Chips in preclinical research offers promising insights and efficiencies, crucial for advancing drug development and reducing human suffering.
-
Scaling Up Your Methods With USP <621> - Part 2: Hardware
9/22/2023
Learn about the hardware changes that allow for scaling and modernization of chromatographic methods and how mismatching particle size and liquid chromatographic systems can result in poor performance.
-
Pursuing Venture Philanthropy With Opus Genetics: The Business Of Biotech
8/10/2022
Explore new, more agile approaches to overcoming the advanced therapy obstacles inherent to bringing rare disease treatments to market.
-
Novel Chemically Defined, Animal Component Free Medium For Vero Cells And Virus Production For Human And Animal Vaccines
9/2/2022
We examinea a chemically defined, serum-free, animal-component free medium that demonstrated excellent results in Vero cell growth and virus yield in both 2D and 3D culture systems.